196 related articles for article (PubMed ID: 24064558)
1. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
2. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
3. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
5. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.
Dix D; Cellot S; Price V; Gillmeister B; Ethier MC; Johnston DL; Lewis V; Michon B; Mitchell D; Stobart K; Yanofsky R; Portwine C; Silva M; Bowes L; Zelcer S; Brossard J; Traubici J; Allen U; Beyene J; Sung L
Clin Infect Dis; 2012 Dec; 55(12):1608-14. PubMed ID: 22955431
[TBL] [Abstract][Full Text] [Related]
6. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
8. Infections with viridans group streptococci in children with cancer.
Reilly AF; Lange BJ
Pediatr Blood Cancer; 2007 Nov; 49(6):774-80. PubMed ID: 17588233
[TBL] [Abstract][Full Text] [Related]
9. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
10. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.
Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Clin Microbiol Infect; 2004 Oct; 10(10):899-903. PubMed ID: 15373884
[TBL] [Abstract][Full Text] [Related]
11. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
13. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
14. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
16. Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML).
Nolt D; Lindemulder S; Meyrowitz J; Chang BH; Malempati S; Thomas G; Stork L
Pediatr Blood Cancer; 2015 Jul; 62(7):1149-54. PubMed ID: 25728418
[TBL] [Abstract][Full Text] [Related]
17. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
18. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.
Gamis AS; Howells WB; DeSwarte-Wallace J; Feusner JH; Buckley JD; Woods WG
J Clin Oncol; 2000 May; 18(9):1845-55. PubMed ID: 10784625
[TBL] [Abstract][Full Text] [Related]
19. High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy.
El Kebbi O; Prather CS; Elmuti L; Khalifeh M; Alali M
Sci Rep; 2023 Apr; 13(1):5627. PubMed ID: 37024512
[TBL] [Abstract][Full Text] [Related]
20. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]